Skip to content

LTGO - Latigo Biotherapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchL

Latigo Biotherapeutics, Inc. Common Stock

LTGO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

L

LTGOLatigo Biotherapeutics, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $22.47
52-wk low: $17.22
Prev close: $21.15
Mkt cap: $1.20B
Profit margin: +0.0%
Op margin: +0.0%

Smart money

Insiders have been net buying.

Insiders

What insiders are doing

2 trades · 6 mo

Bought$5.0M

Buys (2)

FC
Foresite Capital Management V, Llc
10% · Cluster · Aug 11
$2.5M
bought
TJ

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.2B

Valuation

Quality

Operating margin0.0%
ROE0.0%
ROA

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: LTGO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.20B

Analysts

What do analysts expect?

No data yet

No analyst coverage yet for this stock.

We show it when enough analysts cover the stock.

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

ROE

+0.0%

Tananbaum James B.

Dir, 10% · Cluster · Aug 11

$2.5M

bought

Coverage gaps for LTGO

No tracked fund holdings this quarter
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

0.0%

Growth